| Biocoll | Percoll
| Mitogens |
| Back to
Contents | Home |
BICOLL CELL
separating soLUTION
Storage +2 - +
Biocoll separating solution does
contain a polymer with
a molecular weight of approx. 400.000
Instruction how to dilute the stock solution of
Biocoll (density 1.090 g/ml; cat. no.L6125) with PBS (cat. no.
L1823/0):
|
desired |
vol % of |
PBS
|
|
density (g/ml) |
Biocoll 1.090 |
(vol %) |
|
1.080 |
88.2 |
11.8 |
|
1.075 |
82.4 |
17.6 |
|
1.070 |
76.5 |
23.5 |
|
1.065 |
70.6 |
29.4 |
|
1.060 |
64.7 |
35.3 |
|
1.055 |
58.8 |
41.2 |
|
1.050 |
52.9 |
47.1 |
|
1.045 |
47.1 |
52.9 |
|
1.040 |
41.2 |
58.8 |
|
1.035 |
35.3 |
64.7 |
|
1.030 |
29.4 |
70.6 |
All amounts given for
a temperature of +20°C. Only PBS w/o Ca2+/Mg2+
is suitable, since these ions influence agglomeration and increase formation of cell
clusters.
![]()
separating soLUTION -
percoll®
Storage +2 - +8oC
The basis of Percoll
are silica gel particles, coated with PVP (polyvinyl pyrrolidone).
BIOCHROM ready-to-use preparations are already adjusted to physiological values
of osmolality and pH. Any desired densities from Percoll (cat. no. L6143/5) can
conveniently be prepared with PBS (cat. no. L1823/5), using the formula:
Vol. % Percoll (1.124 g/ml) =
|
desired |
Percoll
|
PBS
|
|
density in g/ml |
Cat.No. |
Cat.No. |
|
|
L6143 / 5 |
L1825 |
|
1.063 |
48.74 ml |
51.26 ml |
|
1.068 |
52.94 ml |
47.06 ml |
|
1.077 |
60.50 ml |
39.50 ml |
|
1.100 |
79.83 ml |
20.17 ml |
|
1.113 |
90.76 ml |
9.24 ml |
All amounts are given
for a temperature of
+20°C. Only PBS w/o Ca2+/Mg2+
is suitable, since these ions might influence
agglomeration and hence separating of cell clusters.
Biocoll and Percoll separating solutions
|
Parameter |
Biocoll+
Amidotrizoic acid-Na-salt
|
Percoll +
PBS
|
|
Viscosity |
3.6 cP at +20oC |
1.5 cP at +200C |
|
|
|
more preserving
separation, |
|
|
|
better yield. |
|
|
|
|
|
Cytoxicity |
inhibition of
mitosis following long contact, |
no inhibition |
|
|
alteration of cell
density. |
no density
alterations |
|
|
|
|
|
Phagocytosis |
none |
monocytes may
ingest silicon particles, |
|
|
|
but are not
activated. |
Storage +2 - + 25oC
|
|
Cat. No. |
Unit
|
|
Biocoll separating
solution |
L6113 |
100 ml |
|
Density 1.077 g/ml,
isoton |
L6115 |
500 ml |
|
|
|
|
|
Biocoll separating
solution |
L6125 |
500 ml |
|
Density 1.09 g/ml,
isoton |
|
|
|
|
|
|
|
Biocoll separating
solution |
L6155 |
500 ml |
|
Density 1.10 g/ml,
isoton |
|
|
Storage +2 -+8°C
|
|
Cat. No. |
Unit
|
|
Percoll separating
solution |
L6133 |
100 ml |
|
Density 1.077 g/ml,
isoton |
L6135 |
500 ml |
|
|
|
|
|
Percoll separating
solution |
L6143 |
100 ml |
|
Density 1.124 g /
ml, isoton |
L6145 |
500 ml |
Storage+2-+
Percoll 80%, and
Percoll 40% are diluted using Ham's F-10 (10x) in a ratio of 8:2 (Percoll 80),
and 4:6 (Percoll 40).Osmolality is adjusted to 275 - 297 mosm/kg H2O,
and pH to 7.24 ± 0.25.
|
|
Cat. No. |
Unit
|
|
Percoll 80% |
L6173 |
100 ml |
|
|
|
|
|
|
|
|
|
Percoll 40 % |
L6163 |
100 ml |
|
|
|
·
Biocoll separating solution (D=1.077at+20°C) is given to 15 or 25 ml-centrifugal tubes In volumes of 7 ml and 10 ml, resp.
·
Equal parts of
heparinized whole blood (50 l U/ml heparin, stabilisator free) and culture medium are mixed and carefully applied over
Biocoll separating solution.
·
Centrifuge 1200 G for
20 min.
·
Take layer of enriched (70 -100%) lymphocytes
(between plasma and Biocoll) with a Pasteur's pipette and wash twice in culture
medium:
1. for 10 min at 300 G
2. for 10 min at 200 G
·
Cell counting as
usual.

Separating
mononuclear cells (lymphocytes and monocytes) from whole human blood using
Percoll
·
Put 6 ml of Percoll
(1.077 g/ml) info a centrifugal tube of 25 ml.
·
Dilute heparinized
whole blood (25 U/ml) by an equal volume of culture medium or physiological
saline.
·
Carefully place
diluted whole blood on Percoll (up to 20 ml per tube) and centrifuge at 400 G
for 30 min at room temperature.
·
Mononuclear cells are
readily visible as a white stratum between plasma and Percoll, erythrocytes
together with granulocytes are found in the sediment.
·
Mononuclear cells are
harve-5ted with a Pasteur's pipette.
·
Cell suspension is
diluted with an equal volume of culture medium or saline, well mixed and washed
2 or 3 times in culture medium (250 G/10 min at+2 - +
Media - suitable for lymphocyte culture
|
|
Cat. No. |
|
RPMI 1640 - liquid medium |
F1213 / F1215 |
|
RPMI 1640- liquid medium |
F1235 |
|
Medium 199 with Earle's salts - liquid medium |
F0663 / F0665 |
|
RPMI 1640 with stable glutamine - liquid medium |
FG1383 / FG1385 |
|
VLE RPMI 1640 |
F1415 |
|
VLE RPMI 1640 with stable glutamine |
FG1415 |
![]()
Storage +2 - +8°C
About 100 years ago,
a pro-tein, extracted from Canavalia ensiformis, was found to
agglutinate human erythrocytes- The surified protein was named Concanavalin A
(Con A). Similiar agglutinins from other plant species were identified (80 % of
them are leguminose species), that agglutinate erythrocytes either specific or
blood group specie.They were named as phytohemagglutinins.
Molecular basis of
agglutination:
Phytohemagglutimns do
have several binding sites for carbohydrate derivates located in the cell
membrane. For instance, Con A readily binds to mannose and glucose. PHA
recognizes more complex oligosaccharides. By means or multiple binding,
next-neighbour cells are agglutinated.
Molecular basis of
mitogenic stimulation:
Lymphocytes proved to
have an increased mitosis rate under the influence of this phytohemagglutinin.
Binding of the mitogen to the cell membrane seems to increase the
molecular/information flow between the cell and its environment. Increased
membrane permeability activates the synthesis of proteins and nucleic acids, The synthesis rare for messenger
substances like lymphokines (e.g. IL-2) is also increased.
Nomenclature
Earlier nomenclature f phytohemagglutinies
mostly referred to their purification level: PHA M, e.g., was named
after residual content of mucoprotein, whereas PHA P indicated
the pure protein.
The recent nomenclature, however, rather
refers to biological characteristics: PHA P preferrably agglutinizes erytrocytes,
and is therefore now termed PHA E (cat.no. M 5040). PHA M (cat.no. M
5030) was similarly re-named to PHA L, due to its particularly
stimulating effect on lymphocytes.
|
|
Cat. No. |
Unit |
Protein Content |
|
Phytohemaaglutinin (PHA) L |
M5030
|
1 x (6 x 5 ml) |
1.2 mg |
|
- lyophilized, for 5 ml |
|
|
|
|
|
|
|
|
|
Phytohemaaglutinin (PHA) E |
M5040 |
1 x (6 x 5 ml) |
2.4 mg |
|
- lyophilized, for 5 ml |
|
|
|
|
|
|
|
|
|
Concanavalin A (Con A) |
M5050 |
1 x (6 x 5 ml) |
0.4 mg |
|
- lyophilized, for 5 ml |
|
|
|
|
|
|
|
|
|
Pokeweed Mitogen (PWM) |
M5060 |
1 x (6 x 5 ml) |
0.4 mg |
Following re-constitution in 5 ml A. dest., apply 1 ml per 100 ml
medium.
Specific activity of these lectins is routinely tested
in a short time assay (72 – 80 hrs) using peripheric human lymphocytes. The
following test protocol applies:
·
Separation of human lymphocytes by means of Biocoll
density centrifugation
·
1 x 10 lymphocytes/ml (0,2 ml in microplates)
·
Culture medium: RPMI 1640,
·
10 µ/ml lectin
·
Radioactive labelling: 0,2 µCi 3H-thymidine per test
plate (spec. act. 2Ci/mM)
·
Culture: 72 – 80 hrs at
Lectin content is then standardized according to
maximum stimulation values.
![]()